Results 161 to 170 of about 1,041,335 (309)

Efficient automated error detection in medical data using deep-learning and label-clustering. [PDF]

open access: yesSci Rep, 2023
Nguyen TV   +6 more
europepmc   +1 more source

Patient therapy outcome modeling in cancer organoids is improved by cancer‐associated fibroblasts and organoid assembly convolution

open access: yesMolecular Oncology, EarlyView.
Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski   +12 more
wiley   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

Author Correction: Efficient automated error detection in medical data using deep-learning and label-clustering. [PDF]

open access: yesSci Rep, 2023
Nguyen TV   +6 more
europepmc   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

A Deep-Learning Error Detection System in Radiation Therapy. [PDF]

open access: yesAnn Biomed Res, 2023
Kump PM, Xia J, Yaddanapudi S, Bai E.
europepmc   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Machine learning for medication error detection: a scoping review protocol. [PDF]

open access: yesBMJ Open
Hêche F   +5 more
europepmc   +1 more source

The DetectDeviatingCells algorithm was a useful addition to the toolkit for cellwise error detection in observational data. [PDF]

open access: yesJ Clin Epidemiol, 2023
Viviani L   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy